GRO Biosciences

Scott Frankenthaler, Manager, Corporate Development is attending the 10th annual G-CAN International Research Symposium!   Organized by GOUT HYPERURICEMIA AND CRYSTAL-ASSOCIATED DISEASE NETWORK, this Symposium highlights the most recent gout and crystal-associated diseases research.   At GRObio, we’re addressing #immunogenicity in #gout therapies. Our ProGly-Uricase promotes tolerance and prevents the emergence of anti-drug antibodies (ADAs)—bringing a novel, safe, and effective solution to patients with severe, refractory gout.   Check out the symposium for more info: https://lnkd.in/eJRe96wb

Join us to celebrate Joey Terranova, Automation Engineer, on his 5-year anniversary at GRObio!     As an automation engineer, Joey develops and implements automation for high-throughput screening, driving GRObio’s R&D, and accelerating our research. From building critical infrastructure to supporting novel therapeutics, Joey wears many hats as a key part of our talented team to keep us moving forward.   Joey’s contributions are invaluable to the entire GRObio team. Thank you, Joey, and congratulations!      #WorkAnniversary

#ICYMI – We're excited to attend the Autoimmunity Pharma & Biotech Partnering Summit in Boston next week!   Don’t miss the chance to connect with our Chief Business Officer, Edward "Tad" Stewart, and Chief Development Officer, Tracey Lodie, to explore collaboration opportunities and discover how we’re developing novel therapeutics to reeducate the immune system and empower patients to live better lives.   You can learn more about our ProGly programs here: https://lnkd.in/eP99hgtJ #Autoimmunity #partnering 

Congratulations to Silvere Pagant on his 3-year anniversary with GRObio!   Silvere has driven major advances in our ProGly-Uricase program for treating refractory #gout. His work on building therapies with our ProGly NSAAs —tolerogenic non-standard amino acids—is helping us break new ground in the efficacy and safety of protein therapeutics.   Thank you, Silvere, for your dedication and innovation at GRObio!   #WorkAnniversary

Happy #Halloween, Everyone!   As you carve pumpkins and enjoy sweet treats, may your day be filled with spooky fun and magical moments. Have a fang-tastic time!

Our Chief Development Officer, Tracey Lodie, and Chief Business Officer, Edward "Tad" Stewart, will be attending the 2024 Autoimmunity Pharma & Biotech Partnering Summit in Boston, November 12-13!   The summit is a great opportunity for GRObio to join other leaders in the #immune tolerance and #autoimmunity space to discuss how we can collaborate to deliver novel, effective therapies for patients. GRObio's innovative ProGly therapeutics employ non-standard amino acids (NSAAs) to prevent anti-drug antibodies (ADA) and enable tolerization without immunosuppression.   Looking to collaborate or learn more? Connect with our leadership at the summit! We can't wait to see you there.   #partnerning #synbio

Join us in celebrating Nadine Anderson on her 3-year anniversary with GRObio!     Nadine’s recent promotion to Senior Scientist II and Team Lead of the Protein Sciences group reflects her exceptional contributions to GRObio’s mission. Nadine’s focus and expertise have been pivotal in powering discovery and development of groundbreaking therapies.   Thank you, Nadine, for your dedication and contributions. Here’s to many more successful years ahead! #WorkAnniversary  

Our CEO, Dan Mandell, recently had an insightful conversation with the legendary George Church—a pioneer in genomics and synthetic biology, and GRO Biosciences co-founder—on the latest episode of the BiotechTV podcast.   In the interview, Dr. Church shared his visionary insights on the future of technology and synthetic biology, the sustainability of life on Earth, and the potential to unlock the mysteries of the human brain. They also discussed applications in biotechnology for GRObio’s Genomically Recoded Organisms (GRO) platform, which originated in Dr. Church’s lab. Ready to dive into the future of biotech? Watch the full episode here: https://lnkd.in/gDzs5-bn   A huge thank you to Brad Loncar from BiotechTV and MassBio for making this important conversation happen!   #SyntheticBiology #Genomics #BiotechInnovation

Congratulations to Maidul Islam on his two-year anniversary with GRObio!   Maidul has been an invaluable part of our team, leveraging his expertise in synthetic chemistry to innovate entirely new approaches to controlling the immune system with non-standard amino acids. We're grateful for all your hard work and dedication, Maidul—thank you for everything you do!   #WorkAnniversary  

In July, GRObio successfully closed a $60M Series B financing. To celebrate this milestone, our team embarked on a "Museum Hack" scavenger hunt at the Museum of Fine Arts, Boston, followed by an unforgettable dinner brimming with creativity, inspiration, and plenty of laughter.   This achievement wouldn’t have been possible without the dedication and unwavering support of our incredible team. Thank you all for your commitment—here’s to the future of groundbreaking innovation and more exciting adventures ahead! On we GRO! #SeriesB #TeamCelebration #mfaBoston